Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.
Boire A, Zou Y, Shieh J, Macalinao DG, Pentsova E, Massagué J.
Cell. 2017 Mar 9;168(6):1101-1113.e13. doi: 10.1016/j.cell.2017.02.025.
PMID:28283064
Disrupting the CD47-SIRPalpha anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.
Gholamin S, Mitra SS, Feroze AH, Liu J, Kahn SA, Zhang M, Esparza R, Richard C, Ramaswamy V, Remke M, Volkmer AK, Willingham S, Ponnuswami A, McCarty A, Lovelace P, Storm TA, Schubert S, Hutter G, Narayanan C, Chu P, Raabe EH, Harsh G 4th, Taylor MD, Monje M, Cho YJ, Majeti R, Volkmer JP, Fisher PG, Grant G, Steinberg GK, Vogel H, Edwards M, Weissman IL, Cheshier SH.
Sci Transl Med. 2017 Mar 15;9(381):eaaf2968. doi: 10.1126/scitranslmed.aaf2968.
PMID:28298418
Leptomeningeal disease.
Groves MD.
Neurosurg Clin N Am. 2011 Jan;22(1):67-78, vii. doi: 10.1016/j.nec.2010.08.006.
PMID:21109151
Pediatric Malignant Peritoneal Mesothelioma With Meningeal Metastasis.
Aldrian D, Neu N, Oberhuber G, Kropshofer G, Müller T, Vogel GF.
J Pediatr Hematol Oncol. 2022 Jan 1;44(1):e272-e274. doi: 10.1097/MPH.0000000000002118.
PMID:33633025
Meningeal metastasis of a malignant peritoneal mesothelioma: A case report and literature review.
Jiang Y, Mei Z, Cao H, Li S, Xu H, Qiu H, Liu Y.
Cancer Biol Ther. 2019;20(12):1409-1415. doi: 10.1080/15384047.2019.1647053. Epub 2019 Aug 14.
PMID:31411522
Leptomeningeal metastasis.
DeAngelis LM, Boutros D.
Cancer Invest. 2005;23(2):145-54.
PMID:15813508
Intrameningioma metastasis: A case-based literature review.
Papadakis BK, Vorrias E, Bräutigam K, Chochlidakis N, Koutsopoulos A, Mavroudis D, Vakis A, Tsitsipanis C.